Healthcare

A judge has rejected part of IVF provider Virtus Health’s bid for redactions in a recent decision from the court temporarily blocking the company from purchasing rival Adora Fertility, saying some of the confidentiality claims were “staggering” and “border on ridiculous.”

Eastern Health and the Royal Women’s Hospital have become the latest hospital operators to be stung with a class action alleging they failed to pay junior doctors for unrostered work hours.

The New South Wales Civil and Administrative Tribunal has struck down another challenge to a public health order mandating COVID-19 vaccinations for healthcare workers, saying it lacked the necessary jurisdiction to review the order’s merits.

The Australian Competition and Consumer Commission has won an injunction to stop Virtus from completing the purchase of rival Adora Fertility until a court has ruled on the competition regulator’s challenge to the acquisition. 

Mobility equipment provider Country Care has taken a law firm to court claiming it gave negligent advice and was responsible for an ACCC price-fixing investigation and subsequent criminal cartel charges.

A Sydney-based plastic surgeon with more than 5 million followers on TikTok has taken the ABC to court to block an upcoming episode of Four Corners about him from running.

IVF provider Virtus Health would be “the author of its own fate” if its proposed acquisition of rival Adora Fertility flopped, a judge has said in hearing the ACCC’s bid for a temporary injunction blocking completion of the planned purchase.

The ACCC has won an interim injunction blocking IVF provider Virtus Health from completing its purchase of rival Adora Fertility on Friday.

The competition regulator has filed court action seeking an injunction to stop Virtus Health from completing the purchase of rival Adora Fertility on Friday while a merger review is still in progress.

Danish drug maker Lundbeck has told the High Court it did not contract away a royalty-free licence to generic drug maker Sandoz to sell blockbuster antidepressant Lexapro, saying such a decision would be commercial “madness”.